T Cell Subsets are Associated with Clinical Activity and Efficacy of 4.5g Intravenous Glucocorticoid for Moderate-To-Severe Thyroid-Associated Ophthalmopathy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
T Cell Subsets are Associated with Clinical Activity and Efficacy of 4.5g Intravenous Glucocorticoid for Moderate-To-Severe Thyroid-Associated Ophthalmopathy
Authors
Keywords
-
Journal
ENDOCRINE RESEARCH
Volume -, Issue -, Pages 1-13
Publisher
Informa UK Limited
Online
2023-06-24
DOI
10.1080/07435800.2023.2219734
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy
- (2022) Irene Campi et al. Frontiers in Endocrinology
- Correlation between Peripheral T Cell Subsets and the Activity of Thyroid-Associated Ophthalmopathy
- (2022) Hong Hu et al. International Journal of Endocrinology
- Characteristics of and reference ranges for peripheral blood lymphocytes and CD4+ T cell subsets in healthy adults in Shanxi Province, North China
- (2020) Dan Xu et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Graves’ disease
- (2020) Terry F. Davies et al. Nature Reviews Disease Primers
- Evidence That Baseline Levels of Low-Density Lipoproteins Cholesterol Affect the Clinical Response of Graves’ Ophthalmopathy to Parenteral Corticosteroids
- (2020) Adriano Naselli et al. Frontiers in Endocrinology
- Current and Emerging Treatment Strategies for Graves’ Orbitopathy
- (2019) Natalia Genere et al. DRUGS
- Context-Dependent Effect of Glucocorticoids on the Proliferation, Differentiation, and Apoptosis of Regulatory T Cells: A Review of the Empirical Evidence and Clinical Applications
- (2019) Luigi Cari et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Glucocorticoids—All-Rounders Tackling the Versatile Players of the Immune System
- (2019) Cindy Strehl et al. Frontiers in Immunology
- Immunohistochemical analysis of human orbital tissue in Graves’ orbitopathy
- (2019) Y. P. Hai et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- New insights into the pathogenesis and nonsurgical management of Graves orbitopathy
- (2019) Peter N. Taylor et al. Nature Reviews Endocrinology
- A single-center retrospective study of factors related to the effects of intravenous glucocorticoid therapy in moderate-to-severe and active thyroid-associated ophthalmopathy
- (2018) Yang Wang et al. BMC Endocrine Disorders
- Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy
- (2018) Giovanna Rotondo Dottore et al. JAMA Ophthalmology
- The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy
- (2018) Yazhuo Huang et al. EYE
- Insights into Local Orbital Immunity: Evidence for the Involvement of the Th17 Cell Pathway in Thyroid-Associated Ophthalmopathy
- (2018) Sijie Fang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Teprotumumab for Thyroid-Associated Ophthalmopathy
- (2017) Terry J. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy
- (2017) Wilmar M Wiersinga Lancet Diabetes & Endocrinology
- Graves’ Disease
- (2016) Terry J. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Smoking was associated with poor response to intravenous steroids therapy in Graves’ ophthalmopathy
- (2015) Lijing Xing et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Pathogenesis of thyroid eye disease: review and update on molecular mechanisms
- (2015) Jwu Jin Khong et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy
- (2015) Terry J. Smith Nature Reviews Endocrinology
- Graves' Ophthalmopathy: Epidemiology and Natural History
- (2014) Yuji Hiromatsu et al. INTERNAL MEDICINE
- A Prospective, Randomized Trial of Intravenous Glucocorticoids Therapy With Different Protocols for Patients With Graves' Ophthalmopathy
- (2014) Wei Zhu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pathogenesis of Graves’ orbitopathy: A 2010 update
- (2014) T. J. Smith JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Markers of Inflammation and Fibrosis in the Orbital Fat/Connective Tissue of Patients with Graves’ Orbitopathy: Clinical Implications
- (2014) Przemyslaw Pawlowski et al. MEDIATORS OF INFLAMMATION
- Immunotherapy for Graves’ ophthalmopathy
- (2014) Mario Salvi Current Opinion in Endocrinology Diabetes and Obesity
- The autoimmunity in Graves's disease
- (2013) Hong Li Frontiers in Bioscience-Landmark
- Epidemiology of Graves’ orbitopathy (GO) and relationship with thyroid disease
- (2012) John H. Lazarus BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Intravenous Glucocorticoids for Graves' Orbitopathy: Efficacy and Morbidity
- (2011) S. Zang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy
- (2011) Andrew G Gianoukakis et al. Current Opinion in Endocrinology Diabetes and Obesity
- A Novel Thyroid Stimulating Immunoglobulin Bioassay Is a Functional Indicator of Activity and Severity of Graves’ Orbitopathy
- (2010) S. D. Lytton et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Monokine Induced by Interferon γ (IFNγ) (CXCL9) and IFNγ Inducible T-Cell α-Chemoattractant (CXCL11) Involvement in Graves’ Disease and Ophthalmopathy: Modulation by Peroxisome Proliferator-Activated Receptor-γ Agonists
- (2009) Alessandro Antonelli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Graves' Ophthalmopathy
- (2009) Luigi Bartalena et al. NEW ENGLAND JOURNAL OF MEDICINE
- Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
- (2008) Luigi Bartalena et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started